Extracellular Vesicle Chromatography for Large-Scale High-Purity Isolation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying extracellular vesicles (EVs) are inadequate in removing impurities such as host cell proteins, DNA, and lipids, leading to heterogeneity and complexity that hinder therapeutic applications, and there is a lack of effective large-scale production techniques.
Innovation Solution
A multistep chromatographic method involving cation exchange chromatography (CEX) and anion exchange chromatography (AEX), optionally followed by mixed-mode chromatography (MMC), with controlled pH differences and multiple iterations, to purify EVs effectively.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If current purification methods are used, then the process is simple, but the purity of EVs is insufficient and impurities remain
Solution Approach 1:
The purification process is divided into multiple sequential chromatography steps (CEX, AEX, and optionally HIC), where each step targets specific impurity classes. This segmentation allows systematic removal of different impurity types (proteins, DNA, lipids) while maintaining EV integrity, resolving the contradiction between achieving high purity and process complexity.
Solution Approach 2:
The chromatography system performs multiple functions: CEX removes anionic impurities, AEX removes cationic impurities, and HIC removes hydrophobic impurities. Each resin type serves a specific purification function, creating a universal platform that addresses diverse impurity classes through a unified chromatographic approach, thereby achieving high purity without excessive complexity.
2Manufacturing precision
If current purification methods are used, then the process is fast, but the selectivity is insufficient to remove significant amounts of impurities
Solution Approach 1:
The method employs parameter changes by adjusting pH levels and ionic strengths across different chromatography steps. CEX operates at lower pH to bind anionic EVs, while AEX operates at higher pH to bind cationic impurities. HIC uses hydrophobic interaction parameters to remove remaining impurities. These parameter variations enable high selectivity for different impurity classes while maintaining efficient processing.
3Productivity
If large-scale production is implemented, then the quantity of EVs increases, but heterogeneity and complexity increase making quality control difficult and costly
Solution Approach 1:
The multistep chromatographic process operates continuously without interruption, with EVs progressing through CEX, AEX, and HIC steps in sequence. This continuous processing ensures consistent purification quality across large production volumes, maintaining heterogeneity control and quality consistency even at scale, thereby resolving the contradiction between productivity and manufacturing precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high-purity EVs with reduced impurities and improved therapeutic potency, enabling large-scale production suitable for clinical use.
Implementation Method 1
contacting the sample with a cation exchange chromatography (CEX) resin
Implementation Method 2
contacting the sample with an anion exchange chromatography (AEX) resin
Data Source
AI summary
The present disclosure relates to multistep chromatographic methods for preparing extracellular vesicles (EVs). The methods were demonstrated to be effective in preparing high-quality EVs in a large scale. The methods enable preparation of EVs for therapeutic and diagnostic applications, and isolation and/or sub-fractionation of EVs with desired properties for specific use.